Global Seasonal Influenza Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Published On: Feb 2019

Format: PDF

Publisher: XYZ Research

Pages: 135

Report ID: 225479

In this report, the global Seasonal Influenza Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2017 and 2023.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Seasonal Influenza Vaccine in these regions, from 2012 to 2023 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Seasonal Influenza Vaccine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Seasonal Influenza Vaccine for each application, including
Children
Adults
Elderly
Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Seasonal Influenza Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2023
1 Market Overview
1.1 Seasonal Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Trivalent Influenza Vaccine
1.2.2 Quadrivalent Influenza Vaccine
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Children
1.3.2 Adults
1.3.3 Elderly
1.3.4 Pregnancy
1.4 New Project SWOT Analysis of Seasonal Influenza Vaccine
1.5 Industry News Analysis of Seasonal Influenza Vaccine

2 Industrial Chain Analysis
2.1 Industry Chain Structure of Seasonal Influenza Vaccine
2.2 Raw Material Analysis of Seasonal Influenza Vaccine
2.2.1 Raw Material A Market Analysis
2.2.2 Raw Material B Market Analysis
2.2.3 Raw Material C Market Analysis
2.3 Labor Cost Analysis of Seasonal Influenza Vaccine
2.4 Other Costs Analysis of Seasonal Influenza Vaccine
2.5 Manufacturing Cost Structure Analysis of Seasonal Influenza Vaccine
2.6 Manufacturing Process Analysis of Seasonal Influenza Vaccine
2.7 Raw Materials Sources of Seasonal Influenza Vaccine Major Manufacturers in 2017
2.8 Downstream Buyers of Seasonal Influenza Vaccine

3 Global Seasonal Influenza Vaccine Players Profiles and Sales Data
3.1 GSK
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.1.2.1 Trivalent Influenza Vaccine
3.1.2.2 Quadrivalent Influenza Vaccine
3.1.2.3 Other
3.1.3 GSK Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.1.4 GSK Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.1.5 GSK Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.2 Sinovac
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.2.2.1 Trivalent Influenza Vaccine
3.2.2.2 Quadrivalent Influenza Vaccine
3.2.2.3 Other
3.2.3 Sinovac Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.2.4 Sinovac Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.2.5 Sinovac Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.3 Changsheng
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.3.2.1 Trivalent Influenza Vaccine
3.3.2.2 Quadrivalent Influenza Vaccine
3.3.2.3 Other
3.3.3 Changsheng Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.3.4 Changsheng Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.3.5 Changsheng Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.4 CCBIO
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.4.2.1 Trivalent Influenza Vaccine
3.4.2.2 Quadrivalent Influenza Vaccine
3.4.2.3 Other
3.4.3 CCBIO Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.4.4 CCBIO Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.4.5 CCBIO Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.5 Aleph Biomedical
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.5.2.1 Trivalent Influenza Vaccine
3.5.2.2 Quadrivalent Influenza Vaccine
3.5.2.3 Other
3.5.3 Aleph Biomedical Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5.4 Aleph Biomedical Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.5.5 Aleph Biomedical Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.6 Sanofi
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.6.2.1 Trivalent Influenza Vaccine
3.6.2.2 Quadrivalent Influenza Vaccine
3.6.2.3 Other
3.6.3 Sanofi Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6.4 Sanofi Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.6.5 Sanofi Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.7 Lanzhou Institute Of Biological Product
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.7.2.1 Trivalent Influenza Vaccine
3.7.2.2 Quadrivalent Influenza Vaccine
3.7.2.3 Other
3.7.3 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7.4 Lanzhou Institute Of Biological Product Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.7.5 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.8 Siobp
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.8.2.1 Trivalent Influenza Vaccine
3.8.2.2 Quadrivalent Influenza Vaccine
3.8.2.3 Other
3.8.3 Siobp Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8.4 Siobp Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.8.5 Siobp Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.9 Hualan Bio
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.9.2.1 Trivalent Influenza Vaccine
3.9.2.2 Quadrivalent Influenza Vaccine
3.9.2.3 Other
3.9.3 Hualan Bio Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.9.4 Hualan Bio Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.9.5 Hualan Bio Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.10 Tianyuan Bio-Pharma
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Seasonal Influenza Vaccine Product Category, Application and Specification
3.10.2.1 Trivalent Influenza Vaccine
3.10.2.2 Quadrivalent Influenza Vaccine
3.10.2.3 Other
3.10.3 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.10.4 Tianyuan Bio-Pharma Different Types of Seasonal Influenza Vaccine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017)
3.10.5 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Volume in Different Applications and Its Application Share
3.11 Vaxtec
3.12 Hissen
3.13 Abbott
3.14 Novartis
3.15 Tasly&Jenner

4 Global Seasonal Influenza Vaccine Market Competition by Manufacturers
4.1 Global Seasonal Influenza Vaccine Sales and Share by Manufacturers (2012-2017)
4.2 Global Seasonal Influenza Vaccine Revenue (Million USD) and Share (%) by Manufacturers (2012-2017)
4.3 Market Concentration Rate
4.3.1 Top 3 Seasonal Influenza Vaccine Manufacturer Market Share
4.3.2 Top 6 Seasonal Influenza Vaccine Manufacturer Market Share
4.4 Market Competition Trend

5 Global Seasonal Influenza Vaccine Market Analysis by Regions
5.1 Global Seasonal Influenza Vaccine Sales, Revenue and Market Share by Regions
5.1.1 Global Seasonal Influenza Vaccine Sales by Regions (2012-2017)
5.1.2 Global Seasonal Influenza Vaccine Revenue by Regions (2012-2017)
5.2 North America Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
5.3 Europe Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
5.4 Asia-Pacific Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
5.5 South America Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
5.6 Middle East and Africa Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

6 North America Seasonal Influenza Vaccine by Countries
6.1 North America Seasonal Influenza Vaccine Sales, Revenue and Market Share by Countries
6.1.1 North America Seasonal Influenza Vaccine Sales by Countries (2012-2017)
6.1.2 North America Seasonal Influenza Vaccine Revenue by Countries (2012-2017)
6.2 United States Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
6.3 Canada Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
6.4 Mexico Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

7 Europe Seasonal Influenza Vaccine by Countries
7.1 North America Seasonal Influenza Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Europe Seasonal Influenza Vaccine Sales by Countries (2012-2017)
7.1.2 Europe Seasonal Influenza Vaccine Sales by Countries (2012-2017)
7.2 Germany Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
7.3 France Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
7.4 UK Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
7.5 Russia Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
7.6 Italy Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

8 Asia-Pacific Seasonal Influenza Vaccine by Countries
8.1 Asia-Pacific Seasonal Influenza Vaccine Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Seasonal Influenza Vaccine Sales by Countries (2012-2017)
8.1.2 Asia-Pacific Seasonal Influenza Vaccine Sales by Countries (2012-2017)
8.2 China Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
8.3 Japan Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
8.4 Korea Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
8.5 India Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
8.6 Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

9 South America Seasonal Influenza Vaccine by Countries
9.1 South America Seasonal Influenza Vaccine Sales, Revenue and Market Share by Countries
9.1.1 South America Seasonal Influenza Vaccine Sales by Countries (2012-2017)
9.1.2 South America Seasonal Influenza Vaccine Sales by Countries (2012-2017)
9.2 Brazil Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
9.3 Argentina Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
9.4 Columbia Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

10 Middle East and Africa Seasonal Influenza Vaccine by Countries
10.1 Middle East and Africa Seasonal Influenza Vaccine Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Seasonal Influenza Vaccine Sales by Countries (2012-2017)
10.1.2 Middle East and Africa Seasonal Influenza Vaccine Sales by Countries (2012-2017)
10.2 Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
10.3 UAE Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
10.4 Egypt Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
10.5 Nigeria Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)
10.6 South Africa Seasonal Influenza Vaccine Sales and Growth Rate (2012-2017)

11 Global Seasonal Influenza Vaccine Market Segment by Type
11.1 Global Seasonal Influenza Vaccine Sales, Revenue and Market Share by Type (2012-2017)
11.1.1 Global Seasonal Influenza Vaccine Sales and Market Share by Type (2012-2017)
11.1.2 Global Seasonal Influenza Vaccine Revenue and Market Share by Type (2012-2017)
11.2 Trivalent Influenza Vaccine Sales Growth Rate and Price
11.2.1 Global Trivalent Influenza Vaccine Sales Growth Rate (2012-2017)
11.2.2 Global Trivalent Influenza Vaccine Price (2012-2017)
11.3 Quadrivalent Influenza Vaccine Sales Growth Rate and Price
11.3.1 Global Quadrivalent Influenza Vaccine Sales Growth Rate (2012-2017)
11.3.2 Global Quadrivalent Influenza Vaccine Price (2012-2017)
11.4 Other Sales Growth Rate and Price
11.4.1 Global Other Sales Growth Rate (2012-2017)
11.4.2 Global Other Price (2012-2017)
11.5 Sales Growth Rate and Price
11.5.1 Global Sales Growth Rate (2012-2017)
11.5.2 Global Price (2012-2017)
11.6 Sales Growth Rate and Price
11.6.1 Global Sales Growth Rate (2012-2017)
11.6.2 Global Price (2012-2017)

12 Global Seasonal Influenza Vaccine by Application
12.1 Global Seasonal Influenza Vaccine Sales Market Share by Application (2012-2017)
12.2 Children Sales Growth Rate (2012-2017)
12.3 Adults Sales Growth Rate (2012-2017)
12.4 Elderly Sales Growth Rate (2012-2017)
12.5 Pregnancy Sales Growth Rate (2012-2017)
12.6 Sales Growth Rate (2012-2017)

13 Global Seasonal Influenza Vaccine Market Forecast (2018-2023)
13.1 Global Seasonal Influenza Vaccine Sales Volume, Revenue and Price Forecast (2018-2023)
13.1.1 Global Seasonal Influenza Vaccine Sales Volume and Growth Rate Forecast (2018-2023)
13.1.2 Global Seasonal Influenza Vaccine Revenue and Growth Rate Forecast (2018-2023)
13.1.3 Global Seasonal Influenza Vaccine Price and Trend Forecast (2018-2023)
13.2 Global Seasonal Influenza Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023)
13.2.1 Global Seasonal Influenza Vaccine Sales Volume and Growth Rate Forecast by Regions (2018-2023)
13.2.2 Global Seasonal Influenza Vaccine Revenue and Growth Rate Forecast by Regions (2018-2023)
13.2.3 Global Seasonal Influenza Vaccine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Seasonal Influenza Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.4 North America (United States, Canada and Mexico) Seasonal Influenza Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.5 Europe (Germany, France, UK, Russia and Italy) Seasonal Influenza Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Seasonal Influenza Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.7 South America (Brazil, Argentina, Columbia) Seasonal Influenza Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.2.8 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Seasonal Influenza Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2023)
13.3 Global Seasonal Influenza Vaccine Sales Volume, Revenue and Price Forecast by Type (2018-2023)
13.3.1 Global Seasonal Influenza Vaccine Sales Forecast by Type (2018-2023)
13.3.2 Global Seasonal Influenza Vaccine Revenue Forecast by Type (2018-2023)
13.3.3 Global Seasonal Influenza Vaccine Price Forecast by Type (2018-2023)
13.4 Global Seasonal Influenza Vaccine Sales Volume Forecast by Application (2018-2023)
13.4.1 Global Seasonal Influenza Vaccine Sales Forecast by Application (2018-2023)
13.4.2 Global Seasonal Influenza Vaccine Market Share Forecast by Application (2018-2023)

14 Sales Channel, Distributors, Traders and Dealers
14.1 Sales Channel
14.1.1 Direct Marketing
14.1.2 Indirect Marketing
14.1.3 Marketing Channel Future Trend
14.2 Distributors, Traders and Dealers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.2 Analyst Introduction
16.3 Data Source